Ekso Bionics Holdings Inc.
13F holders, Q3 2024 (September 30)28holders
1new positions
1sold out
1famous investor
$1.16avg. 13F price*
At the end of Q3 2024, 28 institutions reported holding Ekso Bionics Holdings Inc. in their 13F filings, unchanged from Q2 2024. 1 opened new positions and 1 sold out. The largest holders were Armistice Capital, LLC ($2.5M), Kent Lake PR LLC ($1.9M) and Vanguard Group Inc. ($690K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Ekso Bionics Holdings Inc.
- CUSIP
- 282644301
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2.5M |
| Exits | 1 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 2,414,198 shares bought and 16,380 shares sold, net +2,397,818 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Armistice Capital, LLC | 0.07% | New | 2,167,000 | $2.5M |
| Kent Lake PR LLC | 0.77% | — | 1,669,700 | $1.9M |
| Vanguard Group Inc. | 0.00% | No change | 594,427 | $690K |
| Cresset Asset Management, LLC | 0.00% | Add +71.9% | 515,615 | $598K |
| Geode Capital Management, LLC | 0.00% | Add +23.2% | 167,308 | $194K |
| Renaissance Technologies | 0.00% | Reduce -1.2% | 74,616 | $87K |
| BlackRock, Inc. | 0.00% | — | 54,749 | $64K |
| Compagnie Lombard Odier SCmA | 0.00% | No change | 25,000 | $29K |
| Northern Trust Corp. | 0.00% | No change | 24,850 | $29K |
| State Street Corp. | 0.00% | No change | 23,180 | $27K |
| Atria Wealth Solutions, Inc. | 0.00% | No change | 12,667 | $15K |
| XTX Topco Ltd | 0.00% | Reduce -48.2% | 11,105 | $13K |
| Osaic Holdings, Inc. | 0.00% | Reduce -3.0% | 3,084 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -75.1% | 1,112 | $1K |
| Harbour Investments, Inc. | 0.00% | No change | 458 | $531 |
| Tradewinds Capital Management, LLC | 0.00% | No change | 260 | $302 |
| Bank of America Corp. | 0.00% | Add +58.7% | 246 | $285 |
| NewEdge Advisors, LLC | 0.00% | No change | 200 | $232 |
| UBS Group AG | 0.00% | Reduce -91.4% | 148 | $172 |
| Allworth Financial LP | 0.00% | No change | 64 | $75 |
| Morgan Stanley | 0.00% | Reduce -51.9% | 62 | $72 |
| JPMorgan Chase & Co. | 0.00% | Add +18.4% | 45 | $52 |
| Front Row Advisors LLC | 0.00% | No change | 31 | $36 |
| WR Wealth Planners, LLC | 0.00% | No change | 29 | $34 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 26 | $30 |
| Eukles Asset Management | 0.00% | No change | 13 | $15 |
| Voisard Asset Management Group, Inc. | 0.00% | No change | 4 | $5 |
| Royal Bank of Canada | 0.00% | Reduce -90.7% | 5 | $0 |
"% of holder's portfolio" is EKSO BIONICS HOLDINGS INC's weight in each manager's 13F, not the share of Ekso Bionics Holdings Inc. the manager owns.